Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.870
+0.060 (3.31%)
At close: Oct 17, 2025, 4:00 PM EDT
1.890
+0.020 (1.06%)
After-hours: Oct 17, 2025, 7:59 PM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $67.22 million as of October 17, 2025. Its market cap has increased by 60.52% in one year.
Market Cap
67.22M
Enterprise Value
61.21M
1-Year Change
60.52%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $67.22M, a decrease of -46.07%. That is a compound annual growth rate of -12.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 65.07M | 13.57% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | 124.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |